NY settles Pharmacia pricing case for $2.5M; Merck KGaA now expects faster growth;

@FiercePharma: AstraZeneca plots $150M facility in Russia. Story | Follow @FiercePharma

> New York Attorney General Eric Schneiderman announced a $2.5 million settlement in a pricing-inflation case against Pharmacia, with the recovered funds going to the state's Medicaid program and its drug program for the elderly. Report

> Merck KGaA raised the prospect of faster growth in operating income this year than analysts had expected, citing growth at its new lab gear unit Millipore and lower costs. Story

> Sanofi Aventis plans to buy branded generics and over-the-counter (OTC) consumer healthcare brands in India as part of its strategy to scale up sales from new avenues, a company executive said. News

> The European Parliament has voted in favor of the Falsified Medicines Directive to help stop the flow of counterfeit medicines in Europe. Item

> Medco Health Solutions posted a roughly 11 percent rise in fourth-quarter profit to $378.5 million as the U.S. pharmacy benefit manager increased its mail-order prescriptions of generic drugs. Article

> Ranbaxy Laboratories, India's top drugmaker by sales, swung to a fourth-quarter loss as operating expenses rose from a year earlier. Report

> The National Institute for Health and Clinical Excellence is seeking opinion on its new blood pressure guidelines, which have undergone a major rehaul in a bid to boost the accuracy of diagnosis and save the National Health Service some cash. Item

Biotech News

@FierceBiotech: Fast Company highlights 10 top innovators in biotech. Article | Follow @FierceBiotech

@JohnCFierce: FDA plans to release new biosimilar rules "very soon." Report | Follow @JohnCFierce 

> Forest Labs swallows Clinical Data pill in $1.2B buyout. Story 

> Delcath in a tailspin after FDA punts back NDA. Item

> FDA chief vows fast delivery of new biosimilar rules. Report

> Gilead nabs Calistoga with $600M buyout deal. News

Biotech Research News

> Scripps taps Berkeley chemist to replace Lerner at the helm. Item 

> Drugs pierce blood-brain barrier with 'delivery vector.' Story

> Scientists ID and engineer leukemia-fighting protein. Article

> New 'microworms' could monitor, treat patients. Report

> Singapore infuses another $1B into R&D fund. Story 

> Melanoma-seeking nanoparticle enters testing. Item 

Biotech IT News

> In Canada, a trial data security charade. News 

> Pharma will breathe easy when patient trumps drug. Article

> Virtual studies target antibiotic dosing. News 

> Mobile apps push FDA device boundary. Report 

Manufacturing News

> CMO Troy achieves quest for brand ownership. Article

> Genzyme's bio-ops savvy a job-saver. News 

> Ethicon joins J&J recall train. Article 

> Post-blockbuster era drives ops reform. Story

> Pfizer quantifies green gains. Item

And Finally... A radical overhaul of pharmaceutical supply chains is needed to prepare them for the type of products currently in development, PricewaterhouseCoopers says. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.